Document is current
Any future updates will be listed below
-
Authors
Saunders, Erika F.H.
Brady, Megan
Mukherjee, Dahlia
Baweja, Ritika
Forrest, Lauren N.
Gomaa, Hassaan
Babinski, Dara
He, Fan
Pearl, Amanda M.
Liao, Duanping
Waschbusch, Daniel A.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR002014)
- License Information
-
More Information
Article History
Received: 11 October 2022
Accepted: 20 September 2023
First Online: 2 October 2023
Declarations
:
: ES: none; MB: none; DM: none; RB: none; LF: none; HG: none; DB: research funding from Purdue Pharma within 3 years; FH: none; AP: none; DL: none; DW: research funding from Purdue Pharma and Supernus Pharmaceuticals.
: The creation of the PCARES registry was considered a clinical quality improvement project by the Institutional Review Board (IRB) at the Penn State College of Medicine. It did not meet the criteria for human subject research, so the need for consent to participate was waived by the Penn State College of Medicine IRB, and IRB review and approval was not required for data collection. However, any project using the de-identified PCARES data for research purposes, including this project, requires approval by the Penn State College of Medicine IRB. The Penn State College of Medicine approved to use the PCARES data for the present research purposes (IRB #183 and #7926). This study was conducted according to the ethical principles of the Declaration of Helsinki.
: N/A.
